JANUET 50/500 MG TABLETS

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

METFORMIN HYDROCHLORIDE 500 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Available from:

MERCK SHARP & DOHME ISRAEL LTD

ATC code:

A10BA02

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

MERCK SHARP & DOHME CORP., USA

Therapeutic group:

METFORMIN

Therapeutic indications:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Authorization date:

2009-03-01